Personalizing therapy for ovarian cancer: BRCAness and beyond

J Clin Oncol. 2010 Aug 1;28(22):3545-8. doi: 10.1200/JCO.2010.28.5791. Epub 2010 Jun 14.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carboplatin / therapeutic use
  • Female
  • Gene Expression Profiling
  • Genes, BRCA1*
  • Genes, BRCA2*
  • Humans
  • Mutation*
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / genetics
  • Poly(ADP-ribose) Polymerases / therapeutic use
  • Precision Medicine / methods*

Substances

  • Antineoplastic Agents
  • Carboplatin
  • Poly(ADP-ribose) Polymerases